Leeds Life Sciences Profile
Key Indicators
- Authorised Capital ₹ 1.50 Cr
as on 17-07-2024
- Paid Up Capital ₹ 0.10 M
as on 17-07-2024
- Company Age 17 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 20.07 Cr
as on 17-07-2024
- Satisfied Charges ₹ 20.00 Cr
as on 17-07-2024
- Revenue -17.91%
(FY 2023)
- Profit -60.42%
(FY 2023)
- Ebitda -45.65%
(FY 2023)
- Net Worth 16.96%
(FY 2023)
- Total Assets 9.81%
(FY 2023)
About Leeds Life Sciences
The Corporate was formerly known as Banyan Life Sciences Private Limited. The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.50 Cr and a paid-up capital of Rs 0.10 M.
The company currently has active open charges totaling ₹20.07 Cr. The company has closed loans amounting to ₹20.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Anil Sachdeva, Raj Bhatia, Shivraj Anand, and One other member serve as directors at the Company.
- CIN/LLPIN
U24100DL2007PTC166537
- Company No.
166537
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Aug 2007
- Date of AGM
11 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Leeds Life Sciences?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uday Anand  | Director | 05-May-2018 | Current |
| Shivraj Anand | Director | 26-Mar-2019 | Current |
| Anil Sachdeva | Director | 21-Feb-2012 | Current |
| Raj Bhatia | Director | 21-Feb-2012 | Current |
Financial Performance and Corporate Structure Insights of Leeds Life Sciences.
Leeds Life Sciences Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 17.91% decrease. The company also saw a substantial fall in profitability, with a 60.42% decrease in profit. The company's net worth Soared by an impressive increase of 16.96%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Leeds Life Sciences?
In 2023, Leeds Life Sciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Crimsun Organics Private LimitedActive 8 years 5 monthsAnil Sachdeva and Raj Bhatia are mutual person
Parijat Industries (India) Private LimitedActive 29 years 7 monthsRaj Bhatia, Shivraj Anand and 1 more are mutual person
- Parijat Crop Protection (India) Private LimitedActive 38 years 5 months
Shivraj Anand and Uday Anand are mutual person
- Parijat Holdings Private LimitedActive 8 years 10 months
Shivraj Anand and Uday Anand are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 26 Sep 2023 | ₹20.00 Cr | Open |
Hdfc Bank Limited Creation Date: 30 Jun 2020 | ₹0.69 M | Open |
Hdfc Bank Limited Creation Date: 20 Dec 2019 | ₹3.60 Cr | Satisfied |
How Many Employees Work at Leeds Life Sciences?
Leeds Life Sciences has a workforce of 21 employees as of Apr 07, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Leeds Life Sciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Leeds Life Sciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
